SciSight Ecosystem
SciSightAcademic Intelligence & JCR Rank
WoS SCIE Q3Scopus Q2SCImago #10,104CAS 4区Hybrid

Neoplasma

Abbreviation (ISO):NEOPLASMA
Country: Slovakia•WoS SCIE Quartile: Q3•Scopus SJR: 0.586•SCImago Rank: #10,104•Identifier (ISSN):0028-2685(Print)/1338-4317(Online)•Articles / Year: 143•Estimated Publication Fee (APC): $3,032 USD
Clarivate IF (2026)Q3
2.5
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
43

43 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
143articles/year
4.14% Gold OA•92.59% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.5)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.2)
🔵 Computed
20241.50đ
WoS Q3(IF: 2)
🔵 Computed
20231.50đ
WoS Q3(IF: 3)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.409)
🔵 Computed
20211.50đ
WoS Q3(IF: 2.575)
🔵 Computed
20191.50đ
WoS Q3(IF: 1.771)
🔵 Computed
20181.50đ
WoS Q3(IF: 1.696)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The journal Neoplasma publishes articles on experimental and clinical oncology and cancer epidemiology.

Topics Covered (Recognized by AI)
Biology93.7%Medicine93.1%Genetics86.5%Internal medicine81.6%Chemistry70.6%Biochemistry62.8%Pathology49.3%Cancer42.8%Immunology40.9%Cancer research37.4%Gene33.1%Surgery30.4%Physics23.8%Oncology22.2%Endocrinology21.8%Organic chemistry21.5%Molecular biology20.1%
Primary Research Areas
MedicineOncology
Official WebsiteNLM PubMed CatalogSubmission PortalSCImago Profile

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,104Scopus Q2SCImago Profile
Scopus Coverage:1957-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.586

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
62

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.28

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,032 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations583
3-Year Documents266
Citable Documents265

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
Cancer ResearchQ3
OncologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences
Publication Language
English
Frequency
Bimonthly
Founding Year
1957
Editorial Address
VEDA, SLOVAK ACAD SCIENCES, DUBRAVSKA CESTA 9, BRASTISLAVA, SLOVAKIA, 842 34
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
204/333Q3
ONCOLOGY
JCISCIE
233/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—241
20252.25032
2024254237
2023367421
20223.4091221,046
20212.5751321,326
2020—1662,811
20191.7711192,496
20181.6961592,508
2017—1031,899
2016—1202,403
2015—1412,383
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Neoplasma

WoS Q3
123420182019202120222023202420252.20
Annual Impact Factor Metric
2025:2.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

100% MatchExplore →
100% MatchExplore →
75% MatchExplore →
Record UUID: fbdf723e-b581-41dd-adb4-2cf11a70aec6
Database Updated: 2026-10-01